RxDoctor Payments Data
★ My doctorsLook up a doctor →

Isabel Cordo

Acute Care · Miami, FLNPI 1356169080

Payments from drug & device makers

$1,248in general payments, 2019–2025

Across 56 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$198
  • Lilly USA, LLC$157
  • Eisai Inc.$152
  • Lundbeck LLC$108
  • Mallinckrodt Hospital Products Inc.$79
  • AstraZeneca$68
  • plus $488 from 15 others

What the payments were for

  • Food & beverage$1,248100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie11$198
Lilly USA, LLC6$157
Eisai Inc.6$152
Lundbeck LLC5$108
Mallinckrodt Hospital Products Inc.3$79
AstraZeneca(2 entities)3$68
Otsuka America Pharmaceutical, Inc.3$60
Boston Scientific2$56
UCB, Inc.1$50
EMD Serono, Inc.2$46
Merz Pharmaceuticals, LLC2$40
Teva Pharmaceuticals USA, Inc.2$39
Neurocrine Biosciences, Inc.2$30
Argenx US, Inc.1$28
CSL Behring1$27
TG Therapeutics, Inc.1$23
Xeris Pharmaceuticals, Inc.1$22
Neurelis, Inc.1$20
C2n Diagnostics, LLC1$19
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$15
Amneal Pharmaceuticals LLC1$14

How this compares

$1,248 in reported general payments places this provider in the 75th percentile of 1,150 acute care providers in Florida.

See all acute care providers in Florida →

Other acute care in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →